PT79080B - Einschlussverbindungen von n,n-dimethyl-2-chlor-5-<3-methyl-2-(phenylimino)-4-thiazolin-4-yl>-phenylsulfonamid verfahren zu ihrer herstellung sowie pharmazeutische praeparate - Google Patents
Einschlussverbindungen von n,n-dimethyl-2-chlor-5-<3-methyl-2-(phenylimino)-4-thiazolin-4-yl>-phenylsulfonamid verfahren zu ihrer herstellung sowie pharmazeutische praeparateInfo
- Publication number
- PT79080B PT79080B PT79080A PT7908084A PT79080B PT 79080 B PT79080 B PT 79080B PT 79080 A PT79080 A PT 79080A PT 7908084 A PT7908084 A PT 7908084A PT 79080 B PT79080 B PT 79080B
- Authority
- PT
- Portugal
- Prior art keywords
- thiazolin
- phenylimino
- inclusions
- chloro
- dimethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Materials Engineering (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19833329517 DE3329517A1 (de) | 1983-08-16 | 1983-08-16 | Einschlussverbindung von n,n-dimethyl-2-chlor-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)phenylsulfonamid, verfahren zu ihrer herstellung sowie pharmazeutische praeparate |
Publications (2)
Publication Number | Publication Date |
---|---|
PT79080A PT79080A (de) | 1984-09-01 |
PT79080B true PT79080B (de) | 1986-09-08 |
Family
ID=6206641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT79080A PT79080B (de) | 1983-08-16 | 1984-08-14 | Einschlussverbindungen von n,n-dimethyl-2-chlor-5-<3-methyl-2-(phenylimino)-4-thiazolin-4-yl>-phenylsulfonamid verfahren zu ihrer herstellung sowie pharmazeutische praeparate |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0141076A1 (pt) |
JP (1) | JPS6058969A (pt) |
KR (1) | KR850001737A (pt) |
AU (1) | AU3196184A (pt) |
DE (1) | DE3329517A1 (pt) |
DK (1) | DK392384A (pt) |
ES (1) | ES535135A0 (pt) |
GR (1) | GR80116B (pt) |
PT (1) | PT79080B (pt) |
ZA (1) | ZA846327B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6081166A (ja) * | 1983-10-11 | 1985-05-09 | Fujisawa Pharmaceut Co Ltd | 2−ニトロオキシメチル−6−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法 |
JPH08777B2 (ja) * | 1985-04-08 | 1996-01-10 | 武田薬品工業株式会社 | 経口用抗菌固型組成物 |
YU45837B (sh) * | 1988-01-18 | 1992-07-20 | LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. | Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom |
KR100503200B1 (ko) * | 2000-09-05 | 2005-07-25 | 주식회사 포스코 | 석탄 건조설비의 석탄 불출량 제어장치 |
-
1983
- 1983-08-16 DE DE19833329517 patent/DE3329517A1/de not_active Withdrawn
-
1984
- 1984-08-08 EP EP84109377A patent/EP0141076A1/de not_active Withdrawn
- 1984-08-14 ES ES535135A patent/ES535135A0/es active Granted
- 1984-08-14 KR KR1019840004894A patent/KR850001737A/ko not_active Application Discontinuation
- 1984-08-14 PT PT79080A patent/PT79080B/pt unknown
- 1984-08-14 GR GR80116A patent/GR80116B/el unknown
- 1984-08-15 DK DK392384A patent/DK392384A/da not_active Application Discontinuation
- 1984-08-15 JP JP59169454A patent/JPS6058969A/ja active Pending
- 1984-08-15 AU AU31961/84A patent/AU3196184A/en not_active Abandoned
- 1984-08-15 ZA ZA846327A patent/ZA846327B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GR80116B (en) | 1984-12-14 |
JPS6058969A (ja) | 1985-04-05 |
ZA846327B (en) | 1985-03-27 |
KR850001737A (ko) | 1985-04-01 |
ES8601694A1 (es) | 1985-11-16 |
DK392384A (da) | 1985-02-17 |
DK392384D0 (da) | 1984-08-15 |
PT79080A (de) | 1984-09-01 |
AU3196184A (en) | 1985-02-21 |
DE3329517A1 (de) | 1985-02-28 |
EP0141076A1 (de) | 1985-05-15 |
ES535135A0 (es) | 1985-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3673073D1 (de) | Therapeutische brausemischung sowie verfahren zu deren herstellung. | |
DE3780560D1 (de) | Fuehler und verfahren zu dessen herstellung. | |
DE3485872D1 (de) | Dicke kernverbundstrukturen und verfahren zu deren herstellung. | |
DE68918165D1 (de) | Ultraschallwandler und Verfahren zu dessen Herstellung. | |
DE3688604D1 (de) | Optisches geraet und verfahren zu dessen herstellung. | |
DE3782994D1 (de) | Erythromycin-a-derivate und verfahren zu ihrer herstellung. | |
DE3780532D1 (de) | Amphoterische staerke und verfahren zu deren herstellung. | |
DE68905852D1 (de) | Ultraschallwandler und verfahren zu dessen herstellung. | |
DE3485860D1 (de) | Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate. | |
DE3770853D1 (de) | Zellenseparator und verfahren zu dessen herstellung. | |
PT86331A (de) | Neue pyrrolobenzimidazole verfahren zu ihrer herstellung sowie arzneimittel | |
DE3789504D1 (de) | Optisch aktive azetidinone und verfahren zu deren herstellung. | |
DE3762846D1 (de) | Optisch aktive tolanderivate und verfahren zu deren herstellung. | |
DE3680216D1 (de) | Titandioxidteilchen und verfahren zu ihrer herstellung. | |
DE3887979D1 (de) | Filtermembran und Verfahren zu deren Herstellung. | |
DE3878475D1 (de) | Organopolysiloxanemulsion und verfahren zu ihrer herstellung. | |
DE3686704D1 (de) | Fluessigkristallvorrichtung und verfahren zu ihrer herstellung. | |
DE3484925D1 (de) | Pyrazolochinoline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen. | |
DE3879536D1 (de) | Supraleitender keramischer film und verfahren zu dessen herstellung. | |
DE3219380A1 (de) | Anthracyclinglycosid-verbindungen, verfahren zu deren herstellung, zwischenverbindungen und verfahren zu deren herstellung sowie pharmazeutisches mittel | |
DE3776920D1 (de) | Waessriges praeparat und verfahren zu dessen herstellung. | |
PT79080B (de) | Einschlussverbindungen von n,n-dimethyl-2-chlor-5-<3-methyl-2-(phenylimino)-4-thiazolin-4-yl>-phenylsulfonamid verfahren zu ihrer herstellung sowie pharmazeutische praeparate | |
DE3768411D1 (de) | Sehr reine spirobiindan-bisphenole und verfahren zu deren herstellung. | |
DE3674629D1 (de) | Optischer multiplexer/demultiplexer und verfahren zu dessen herstellung. | |
DE3674263D1 (de) | Siebe sowie verfahren und vorrichtung zu deren herstellung. |